Detalhe da pesquisa
1.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
2.
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.
Cancers (Basel)
; 16(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38611000